Literature DB >> 25205048

2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014) MS Journal Online: Poster Session 1.

.   

Abstract

Year:  2014        PMID： 25205048      PMCID： PMC4244172          DOI： 10.1177/1352458514546077

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.

Authors:  Jeffrey A Cohen; Bhupendra Khatri; Frederik Barkhof; Giancarlo Comi; Hans-Peter Hartung; Xavier Montalban; Jean Pelletier; Tracy Stites; Shannon Ritter; Philipp von Rosenstiel; Davorka Tomic; Ludwig Kappos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-06-25       Impact factor: 10.154

2.  Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Authors:  Kjetil Bjørnevik; Trond Riise; Marianna Cortese; Trygve Holmøy; Margitta T Kampman; Sandra Magalhaes; Kjell-Morten Myhr; Christina Wolfson; Maura Pugliatti
Journal:  Mult Scler       Date:  2015-05-26       Impact factor: 6.312
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.